Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder

ClinicalTrials.gov ID: NCT00383786

Public ClinicalTrials.gov record NCT00383786. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 3:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder

Study identification

NCT ID
NCT00383786
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Baylor College of Medicine
Other
Enrollment
47 participants

Conditions and interventions

Conditions

Interventions

  • NK1 Antagoist (GR205171) Drug
  • Psychophysiology (Trauma Script) Procedure
  • Psychophysiology (Verbal Threat) Procedure
  • Psychophysiology (Fear Conditioning) Procedure
  • Psychophysiology (Affective Modulation) Procedure
  • Psychophysiology (Heart rate variability) Procedure
  • Lumbar Puncture Procedure
  • 24-hour plasma sampling Procedure
  • MRI Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2006
Primary completion
May 31, 2009
Completion
May 31, 2009
Last update posted
Jul 30, 2019

2006 – 2009

United States locations

U.S. sites
2
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland 20892
Mt. Sinai Medical Center New York New York 10029-0574

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00383786, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00383786 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →